+499.5%
MRNA vs GPN
+8.1%
+491.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GPN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.8% | -3.1% | -2.6% |
| 7D | +5.5% | +0.8% | +4.7% | +5.0% |
| 30D | +158.7% | +5.8% | +152.9% | +154.0% |
| 3M | +182.1% | +37.0% | +145.1% | +154.6% |
| 6M | +151.8% | +20.1% | +131.7% | +135.1% |
| YTD | +393.6% | +20.4% | +373.1% | +355.0% |
| 1Y | +499.5% | +7.4% | +492.0% | +493.1% |
| All | +499.5% | +8.1% | +491.4% | +493.1% |
Cumulative growth
Daily Returns
Daily percentage return beside GPN.
Daily Out/Under-Performance
Portfolio return minus GPN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GPN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GPN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling